FDA 483 - FHC, Inc. - July 10, 2025

FHC, Inc., a medical device manufacturer in Bowdoin, ME, was cited with two observations during an FDA inspection. The firm failed to adequately establish and implement complaint handling procedures, resulting in incomplete investigations for specific medical device platforms. Additionally, the company did not timely communicate changes to design validation and risk assessment documents, leading to the use of outdated information.